NCT00620542
CRESTOR Athero Imaging Head to Head IVUS Study
See it on ClinicalTrials.gov ↗1,039 people
26.4%
73.6%
274 womenmiddle line = equal numbers765 men
- Phase
- PHASE3
- Paid for by
- AstraZeneca
- Finished
- 2011-06
- Health conditions
- Coronary Atherosclerosis
- Who could join
- Anyone
- Ages
- 18 Years – 75 Years
- Average age
- mean 57.6 years
- Age 65+
- 23.3%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Patients who have symptoms consistent with moderate or greater severity of Congestive Heart Failure (CHF).”
Study titles and rules are shown in their original English.